d.rizik, tryton breakfast symposium_real world applications

17
Tryton Breakfast Symposium: Real World Applications David G. Rizik, M.D., F.A.C.C., F.S.C.A.I. Chief Scientific Officer Director of Structural & Coronary Interventions HonorHealth and the Scottsdale - Lincoln HealthNetwork HonorHealth / Scottsdale - Lincoln Health Network

Upload: trytonmedical

Post on 14-Apr-2017

54 views

Category:

Healthcare


0 download

TRANSCRIPT

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Tryton Breakfast Symposium:Real World Applications

David G. Rizik, M.D., F.A.C.C., F.S.C.A.I.Chief Scientific Officer

Director of Structural & Coronary InterventionsHonorHealth and the Scottsdale-Lincoln

HealthNetworkHon

orH

ealth

/ Sco

ttsd

ale-

Lin

coln

Hea

lth N

etw

ork

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Disclosure Statement

• Abbott  Vascular:  Medical  Advisory  Board,  Research  &  Education  Support.

• Boston  Scientific:  Executive  Physician  Council,  Research  &  Education  Support

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

kTryton Side Branch Stent“Save  the  Side  Branch  Strategy”

Open strut architecture

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

kPhantom Model Deployment

Tryton  Side  Branch  Stent

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Tryton Deployment Sequence1.  Wire  both  vessels  and  pre-­dilate  SB 2.  Position  Tryton

3.  Perform  P.O.T. 4.  Position  DES  and  remove  ‘jailed’  wire

5.  Deploy  DES  and  re-­wire  SB 6.  Simultaneous  Kissing  Balloon

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Tryton Case

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Dedicated SB Stent: ? Value

• Value:  Bringing  the  predictability &  durability seen  in  straight  lesions  to  bifurcation  lesions

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Provisional  (n=  143)

Tryton  (n=  146)

Dedicated Stent: PredictabilityNear elimination of bailout stenting

Généreux et  al.  Catheter  Cardiovasc Interv.  2015  

Tryton  IDE  Trial  Intended  Population

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

kWhich Lesion? Significant Side Branch

• Side  Branch  Size:   Significant• Angle:     Narrow  and  Wide• Step-­up:     Large  and  Small

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Which Lesion? Significant

• Significant– Appropriate  for  a  2.5  mm  diameter  stent– >2.25  mm  by  visual  estimate

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Angle:    Wide Angle:    Narrow

Which Lesion? Angle

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

SB-­MB  Step-­up:    Large   SB-­MB  Step-­up:    Small

Which Lesion? SB-MB Step-up

Scot

tsda

le-L

inco

ln H

ealth

Net

wor

k

Conclusion

• When  a  dedicated  SB  Stent?Bifurcation  lesions  with  important  Side  Branches

• Procedural  Predictability• Long  term  Durability